Skip to content

MammoStar™ STAR1032Recalls & reported problems

Carbon Medical Technologies, Inc. · Biopsy Site Identifier - Revolve · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00858015005370), received between Feb 18, 2021 and Feb 18, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Expulsion” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Expulsion1

Patient problems

  • Abscess1
  • Foreign Body Reaction1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 18, 2021Expulsion; Expulsion

    IT WAS REPORTED THAT THE PATIENT HAD ONE MAMMOSTAR BIOPSY SITE IDENTIFIER (STAR1032) PLACE AFTER A BIOPSY PROCEDURE APPROXIMATELY 2 YEARS AGO. IN (B)(6) 2020, THE PATIENT CAME TO HOSPITAL BECAUSE THERE WAS A WARM AND RED SPOT ON HER BREAST NEAR THE NIPPLE. THE PHYSICIAN DECIDED TO REMOVE THE SPOT. A LOT OF WHITE/YELLOW LIQUID CAME OUT. THE PHYSICIAN DISCOVERS A "GEL" WITH CERAMIC INSIDE, LOOKING LIKE A MAMMOSTAR. THE ST VAB 2 YRS AGO WAS UNEVENTFUL, THE SCAR IS NOT AT THE SAME AREA OF WHERE THE MARKER CAME OUT.

    Patient problems: Abscess; Foreign Body Reaction

    MAUDE report 11347044 ↗

Other Marker, Radiographic, Implantable devices

All Marker, Radiographic, Implantable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page